Elanco: Past, Present and Future

Since our start, Elanco has worked to empower veterinarians, farmers, and all those caring for animals with the tools needed to help animals live healthy lives.

A Legacy of Innovation

For more than 65 years, we've focused on delivering innovative animal health solutions that solve our customers’ greatest challenges.


Where it All Began

Elanco has helped shape the lives of animals and their care providers for more than half a century.


The Beginning of Elanco Animal Health

Eli Lilly and Company introduces the first antibiotic exclusively for veterinary use.


Growing Rapidly

In 1960, Elanco began growing rapidly into new countries and markets.




Bringing Employees Together

Elanco builds a dedicated global headquarters campus in Greenfield, Ind., bringing together employees from all areas of the company for the first time.


Growing Through Acquisition

Elanco launches Companion Animal parasiticides and acquires long-term partner Ivy Animal Health and launches its Pet Animal businesses.


Elanco adds Monsanto Dairy Business


Elanco Closes Acquisition of Bayer Animal Health

Elanco, now with the addition of Bayer Animal Health, has improved capabilities, scale and global reach to position the company as a long-term leader in the growing global animal health market.


European Expansion

Expands European business: Pfizer vaccines


Elanco acquires Janssen Animal Health.


A Growing Portfolio

With the acquisition of ChemGen, Elanco obtains a portfolio of feed enzyme products for poultry, egg and meat production.


Global Growth and Product Expansion

Elanco's Pet portfolio grows and en

Elanco Foundation

Elanco establishes the Elanco Foundation, which is the first-ever charitable foundation in animal health.

Elanco Completes Separation from Lilly

Elanco becomes a fully-independent pure play animal health company

2021 to date


ESG Summary Report

Elanco releases its first independent ESG Summary Report

Building a healthy enterprise and driving sustainability are essential to our success and leadership in animal health.

Todd Young, executive vice president and CFO

Elanco closes acquisition of Kindred Biosciences

The transaction advances Elanco’s access to the fast-growing $1+ billion dermatology market, complementing the company’s existing pipeline and increasing R&D capability in biologics and monoclonal antibodies.

Animals are the Answer

Sustainable Solutions for Zero Hunger by 2030: A Vision for Animal Agriculture Forum to explore solutions to combat climate change while keeping the world nourished.

Elanco Selected for 2021 FORTUNE’s Change the World List

FORTUNE's list recognizes companies that have made an important social or environmental impact through their profit-making strategy and operations.


MAHABA (Managing Animal Health and Acaricides for a Better Africa)

Elanco Expands Commitment to Creating Shared Value, Launches New Initiative Empowering Small-Scale Producers in Sub-Saharan Africa

Elanco and Ginkgo Bioworks Launch BiomEdit

A new Animal Health Company Leveraging Microbiome Technology

Elanco Breaks Ground on new Headquarters

Elanco Breaks Ground on State-of-the-Art Campus, Creating Indianapolis’ Newest Landmark

You Might Be Interested in...

Get to know Elanco and our perspective on animal health by exploring more articles below.

Purpose-Driven Culture

Learn how we foster a culture that's driven by values and celebrates our company purpose.

Our People

Read about the individuals who shape Elanco and bring our culture and values to life.

Our Initiatives

See how we advance our vision of Food and Companionship Enriching Life through participation in programs and community projects.

Connect with Elanco

Country selector

Elanco's Healthy Purpose, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates. © 2023 Elanco or its affiliates.